Byrne Financial Freedom’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Byrne Financial Freedom’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$558K	Sell	3,526 -101	-3%	-$13.7K	0.22%	64
2026 Q1	$463K	Sell	3,627 -74	-2%	-$9.24K	0.22%	62
2025 Q4	$451K	Buy	3,701 +462	+14%	+$53K	0.21%	64
2025 Q3	$325K	Sell	3,239 -953	-23%	-$85.8K	0.16%	74
2025 Q2	$348K	Sell	4,192 -375	-8%	-$29.9K	0.17%	72
2025 Q1	$370K	Hold	4,567	–	–	0.21%	62
2024 Q4	$411K	Buy	+4,567	New	+$442K	0.18%	60

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Byrne Financial Freedom's XBI Position: Q2 2026 in Review

Byrne Financial Freedom reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 2.8% in Q2 2026, selling an estimated $13.7K and leaving 3,526 shares worth $558K. The position accounts for 0.22% of the portfolio, ranked #64.

Byrne Financial Freedom first reported a position in XBI in Q4 2024 and has held it in 7 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Byrne Financial Freedom held 3,526 shares of State Street SPDR S&P Biotech ETF worth $558K as of Q2 2026.
Byrne Financial Freedom sold 101 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $13.7K.
State Street SPDR S&P Biotech ETF made up 0.22% of Byrne Financial Freedom's portfolio in Q2 2026, its #64 holding.
Byrne Financial Freedom first reported a position in State Street SPDR S&P Biotech ETF in Q4 2024 and has held it in 7 quarters since.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Byrne Financial Freedom's 13F filing for Q2 2026, filed 30 Jul 2026.